Analytik Jena AG is the world’s first company to bring to the market a kit with CE-IVD certification for the molecular diagnostic quantification of hepatitis delta virus (HDV) RNA, thus reaching a major new milestone in the standardization of HDV nucleic acid amplification tests. The Jena-based company is building on years of experience in the development of in vitro diagnostic assays to add the RoboGene® HDV RNA Quantification Kit 2.0 to its range of diagnostics for hepatitis B and C.
As Dr. Ingolf Lachmann, Site Manager for the Analytik Jena subsidiary AJ Roboscreen GmbH in Leipzig explained: “Hepatitis delta is viewed as one of the most severe forms of the viral hepatitis infection. It is solely connected to a coexisting hepatitis B virus (HBV) infection and very frequently leads to chronic cirrhosis of the liver in cases of superinfection. We are very proud to have developed, in addition to RoboGene® ...
